This forecast statistic shows the revenue of pharmaceutical preparation manufacture in Ireland from 2009 to 2012, with forecasts up until 2020. By 2016, revenues of pharmaceutical preparation manufacture in Ireland are projected to reach approximately 37.58 billion U.S. dollars.
Revenue of pharmaceutical preparation manufacture (NACE Rev. 2 C2120) in Ireland from 2009 to 2020 (in million U.S. dollars)
Other statistics that may interest you Pharmaceutical industry in Spain
Overview
6
- Premium Statistic Revenues of top 10 global pharmaceutical markets 2023
- Premium Statistic Top global pharmaceutical markets: growth rate 2023
- Premium Statistic Value of pharmaceutical sales in Spain 2010-2022
- Premium Statistic Pharmaceutical market in Spain 2023, by segment
- Basic Statistic Pharmacies in Spain 2007-2022
- Basic Statistic Employees in the Spanish pharmaceutical industry 2008-2021
International trade
6
- Premium Statistic Value of pharmaceutical products exported from Spain 2002-2022
- Premium Statistic Pharmaceutical imports in Spain 2002-2023
- Premium Statistic Export value of pharmaceutical products in Spain 2023, by type
- Premium Statistic Import value of pharmaceutical products in Spain 2023, by type
- Premium Statistic Pharmaceutical exports value in Spain 2023, by country of destination
- Premium Statistic Pharmaceutical imports value in Spain 2023, by country of origin
Pharmaceutical sales
6
- Premium Statistic Net sales of drugs in pharmacies in Spain 2012-2022
- Premium Statistic Net value of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Value share of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Volume of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Volume share of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Average price of drugs sold in pharmacies in Spain 2022, by therapeutic group
Pharmaceutical expenditure of the National Health System
6
- Premium Statistic Budget expenditure on health benefits & pharmacy in Spain 2003-2024
- Premium Statistic NHS expenditure on prescribed medicines in pharmacies in Spain 2010-2021
- Premium Statistic Average cost of medical prescriptions in pharmacies in Spain 2010-2021
- Premium Statistic State-funded drug prescriptions dispensed in pharmacies in Spain 2010-2021
- Premium Statistic NHS expenditure per prescription dispensed in pharmacies in Spain 2021, by region
- Premium Statistic Share of per capita pharmaceutical expenditure in Spain 2021, by region
Research and development
6
- Premium Statistic Share of total R&D spending in Spain in 2021, by industrial sector
- Premium Statistic R&D expenditure in the pharmaceutical industry in Spain 2008-2022
- Premium Statistic R&D employment within the pharmaceutical industry in Spain 2008-2022
- Premium Statistic Pharmaceutical R&D spending in Spain 2022, by type
- Premium Statistic Internal and external R&D expenditure in the pharmaceutical industry Spain 2012-2022
- Premium Statistic External R&D expenditure in the pharmaceutical industry Spain 2022, by region
Company rankings
6
- Premium Statistic Leading basic pharmaceutical products manufacturers in Spain in 2021
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2021
- Premium Statistic Leading pharmaceutical goods wholesalers in Spain in 2021
- Premium Statistic Corporate reputation of leading pharmaceutical companies in Spain in 2023
- Premium Statistic Leading companies in R&D on biotechnology in Spain 2021
- Basic Statistic Largest private capital increases of biotech companies in Spain 2021
Further related statistics
10
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2019 to 2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Further Content: You might find this interesting as well
Statistics
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2019 to 2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Statista. (February 15, 2016). Revenue of pharmaceutical preparation manufacture (NACE Rev. 2 C2120) in Ireland from 2009 to 2020 (in million U.S. dollars) [Graph]. In Statista. Retrieved November 10, 2024, from https://www.statista.com/forecasts/392974/ireland-pharmaceutical-preparation-manufacture-revenue-forecast-nace-c2120
Statista. "Revenue of pharmaceutical preparation manufacture (NACE Rev. 2 C2120) in Ireland from 2009 to 2020 (in million U.S. dollars)." Chart. February 15, 2016. Statista. Accessed November 10, 2024. https://www.statista.com/forecasts/392974/ireland-pharmaceutical-preparation-manufacture-revenue-forecast-nace-c2120
Statista. (2016). Revenue of pharmaceutical preparation manufacture (NACE Rev. 2 C2120) in Ireland from 2009 to 2020 (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 10, 2024. https://www.statista.com/forecasts/392974/ireland-pharmaceutical-preparation-manufacture-revenue-forecast-nace-c2120
Statista. "Revenue of Pharmaceutical Preparation Manufacture (Nace Rev. 2 C2120) in Ireland from 2009 to 2020 (in Million U.S. Dollars)." Statista, Statista Inc., 15 Feb 2016, https://www.statista.com/forecasts/392974/ireland-pharmaceutical-preparation-manufacture-revenue-forecast-nace-c2120
Statista, Revenue of pharmaceutical preparation manufacture (NACE Rev. 2 C2120) in Ireland from 2009 to 2020 (in million U.S. dollars) Statista, https://www.statista.com/forecasts/392974/ireland-pharmaceutical-preparation-manufacture-revenue-forecast-nace-c2120 (last visited November 10, 2024)
Revenue of pharmaceutical preparation manufacture (NACE Rev. 2 C2120) in Ireland from 2009 to 2020 (in million U.S. dollars) [Graph], Statista, February 15, 2016. [Online]. Available: https://www.statista.com/forecasts/392974/ireland-pharmaceutical-preparation-manufacture-revenue-forecast-nace-c2120